GCP
LRMR icon

GSA Capital Partners’s Larimar Therapeutics LRMR Stock Holding History

GSA Capital Partners’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Buy
+50,078
New +$199K 0.01% 1581
2026
Q1 		– Sell
-102,039
Closed -$389K – 1975
2025
Q4 		$389K Buy
102,039
+20,633
+25% +$80.2K 0.03% 986
2025
Q3 		$263K Sell
81,406
-18,516
-19% -$69.4K 0.02% 1274
2025
Q2 		$289K Buy
+99,922
New +$231K 0.02% 1278
2025
Q1 		– Sell
-148,533
Closed -$575K – 1901
2024
Q4 		$575K Buy
148,533
+41,125
+38% +$271K 0.04% 782
2024
Q3 		$704K Buy
107,408
+55,984
+109% +$450K 0.05% 682
2024
Q2 		$373K Buy
51,424
+22,362
+77% +$171K 0.03% 1147
2024
Q1 		$221K Buy
29,062
+3,830
+15% +$29.8K 0.02% 1364
2023
Q4 		$115K Sell
25,232
-63,981
-72% -$216K 0.01% 1384
2023
Q3 		$352K Buy
89,213
+33,392
+60% +$126K 0.03% 993
2023
Q2 		$175K Buy
55,821
+45,029
+417% +$184K 0.02% 1307
2023
Q1 		$49K Buy
+10,792
New +$56.4K ﹤0.01% 1400
2019
Q3 		– Sell
-881
Closed -$13K – 1566
2019
Q2 		$13K Sell
881
-1,367
-61% -$36.4K ﹤0.01% 1396
2019
Q1 		$74K Sell
2,248
-3,501
-61% -$179K 0.01% 1351
2018
Q4 		$341K Buy
+5,749
New +$568K 0.04% 765
2017
Q3 		– Sell
-6,142
Closed -$259K – 1780
2017
Q2 		$259K Buy
+6,142
New +$314K 0.02% 1363

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

GSA Capital Partners's LRMR Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 50,078 shares worth $153K. The stake represents 0.01% of the portfolio and ranks #1581 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in LRMR as recently as Q4 2025.

GSA Capital Partners first reported a position in LRMR in Q2 2017 and has held it in 16 quarters since. The position peaked at $704K in Q3 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • GSA Capital Partners held 50,078 shares of Larimar Therapeutics worth $153K as of Q2 2026.
  • Larimar Therapeutics was a new GSA Capital Partners position in Q2 2026.
  • Larimar Therapeutics made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1581 holding.
  • GSA Capital Partners first reported a position in Larimar Therapeutics in Q2 2017 and has held it in 16 quarters since.
  • GSA Capital Partners's Larimar Therapeutics position peaked at $704K in Q3 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.